Filed: 8/14/2023ACC: 0001104659-23-091230
📋 What this filing means
SOFINNOVA INVESTMENTS, INC. filed this quarterly 13F‑HR report disclosing 48 equity positions with a total reported market value of $1.53B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
48
Positions
$1.53B
Total AUM (reported)
67.35M
Total Shares
Allocation by class
COM$1.19B78.1%
SPONSORED ADR$208.77M13.7%
CL A$88.53M5.8%
SHS$35.10M2.3%
COMMON SHARES$1.90M0.1%
Portfolio Concentration
Top 3$571.87M37.5%
4–10$417.12M27.3%
11–25$398.80M26.1%
Rest$138.98M9.1%
Top 3 weight
37.5%
Top 10 weight
64.8%
Voting Authority Distribution
Total shares with voting rights: 67.35M
Sole
Full voting authority
67.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole48
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings48
Rows:
Karuna Therapeutics Inc
SOLEShares1.38M
TypeSH
Market value$299.50M
19.62%
Sole
1.38M
Shared
0.00
None
0.00
Natera Inc
SOLEShares3.10M
TypeSH
Market value$150.87M
9.88%
Sole
3.10M
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares1.70M
TypeSH
Market value$121.49M
7.96%
Sole
1.70M
Shared
0.00
None
0.00
Intuitive Surgical Inc
SOLEShares201.18K
TypeSH
Market value$68.79M
4.51%
Sole
201.18K
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares754.03K
TypeSH
Market value$67.30M
4.41%
Sole
754.03K
Shared
0.00
None
0.00
Aerovate Therapeutics Inc
SOLEShares3.76M
TypeSH
Market value$64.46M
4.22%
Sole
3.76M
Shared
0.00
None
0.00
Merck & Co Inc
SOLEShares527.37K
TypeSH
Market value$60.85M
3.99%
Sole
527.37K
Shared
0.00
None
0.00
Vera Therapeutics Inc
SOLEShares3.47M
TypeSH
Market value$55.65M
3.64%
Sole
3.47M
Shared
0.00
None
0.00
Vertex Pharmaceuticals Inc
SOLEShares145.30K
TypeSH
Market value$51.13M
3.35%
Sole
145.30K
Shared
0.00
None
0.00
Exelixis Inc
SOLEShares2.56M
TypeSH
Market value$48.94M
3.21%
Sole
2.56M
Shared
0.00
None
0.00
Dexcom Inc
SOLEShares370.72K
TypeSH
Market value$47.64M
3.12%
Sole
370.72K
Shared
0.00
None
0.00
IDEXX Laboratories Inc
SOLEShares70.67K
TypeSH
Market value$35.49M
2.32%
Sole
70.67K
Shared
0.00
None
0.00
Immatics NV
SOLEShares3.04M
TypeSH
Market value$35.10M
2.30%
Sole
3.04M
Shared
0.00
None
0.00
Syndax Pharmaceuticals Inc
SOLEShares1.58M
TypeSH
Market value$33.12M
2.17%
Sole
1.58M
Shared
0.00
None
0.00
Boston Scientific Corp
SOLEShares608.86K
TypeSH
Market value$32.93M
2.16%
Sole
608.86K
Shared
0.00
None
0.00
Reata Pharmaceuticals Inc
SOLEShares322.47K
TypeSH
Market value$32.88M
2.15%
Sole
322.47K
Shared
0.00
None
0.00
Cytokinetics Inc
SOLEShares843.23K
TypeSH
Market value$27.51M
1.80%
Sole
843.23K
Shared
0.00
None
0.00
Inhibrx Inc
SOLEShares998.28K
TypeSH
Market value$25.92M
1.70%
Sole
998.28K
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc
SOLEShares828K
TypeSH
Market value$23.36M
1.53%
Sole
828K
Shared
0.00
None
0.00
Inozyme Pharma Inc
SOLEShares3.66M
TypeSH
Market value$20.36M
1.33%
Sole
3.66M
Shared
0.00
None
0.00
Vir Biotechnology Inc
SOLEShares788.12K
TypeSH
Market value$19.33M
1.27%
Sole
788.12K
Shared
0.00
None
0.00
Geron Corp
SOLEShares5.43M
TypeSH
Market value$17.43M
1.14%
Sole
5.43M
Shared
0.00
None
0.00
Baxter Intl Inc
SOLEShares362.20K
TypeSH
Market value$16.50M
1.08%
Sole
362.20K
Shared
0.00
None
0.00
IDEAYA Biosciences Inc
SOLEShares664.75K
TypeSH
Market value$15.62M
1.02%
Sole
664.75K
Shared
0.00
None
0.00
ImmunoGen Inc
SOLEShares827.32K
TypeSH
Market value$15.61M
1.02%
Sole
827.32K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Karuna Therapeutics IncSOLE | COM | 1.38M | SH | $299.50M 19.62% | 1.38M | 0.00 | 0.00 |
Natera IncSOLE | COM | 3.10M | SH | $150.87M 9.88% | 3.10M | 0.00 | 0.00 |
AstraZeneca PLCSOLE | SPONSORED ADR | 1.70M | SH | $121.49M 7.96% | 1.70M | 0.00 | 0.00 |
Intuitive Surgical IncSOLE | COM | 201.18K | SH | $68.79M 4.51% | 201.18K | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 754.03K | SH | $67.30M 4.41% | 754.03K | 0.00 | 0.00 |
Aerovate Therapeutics IncSOLE | COM | 3.76M | SH | $64.46M 4.22% | 3.76M | 0.00 | 0.00 |
Merck & Co IncSOLE | COM | 527.37K | SH | $60.85M 3.99% | 527.37K | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 3.47M | SH | $55.65M 3.64% | 3.47M | 0.00 | 0.00 |
Vertex Pharmaceuticals IncSOLE | COM | 145.30K | SH | $51.13M 3.35% | 145.30K | 0.00 | 0.00 |
Exelixis IncSOLE | COM | 2.56M | SH | $48.94M 3.21% | 2.56M | 0.00 | 0.00 |
Dexcom IncSOLE | COM | 370.72K | SH | $47.64M 3.12% | 370.72K | 0.00 | 0.00 |
IDEXX Laboratories IncSOLE | COM | 70.67K | SH | $35.49M 2.32% | 70.67K | 0.00 | 0.00 |
Immatics NVSOLE | SHS | 3.04M | SH | $35.10M 2.30% | 3.04M | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | COM | 1.58M | SH | $33.12M 2.17% | 1.58M | 0.00 | 0.00 |
Boston Scientific CorpSOLE | COM | 608.86K | SH | $32.93M 2.16% | 608.86K | 0.00 | 0.00 |
Reata Pharmaceuticals IncSOLE | CL A | 322.47K | SH | $32.88M 2.15% | 322.47K | 0.00 | 0.00 |
Cytokinetics IncSOLE | COM | 843.23K | SH | $27.51M 1.80% | 843.23K | 0.00 | 0.00 |
Inhibrx IncSOLE | COM | 998.28K | SH | $25.92M 1.70% | 998.28K | 0.00 | 0.00 |
Zentalis Pharmaceuticals IncSOLE | COM | 828K | SH | $23.36M 1.53% | 828K | 0.00 | 0.00 |
Inozyme Pharma IncSOLE | COM | 3.66M | SH | $20.36M 1.33% | 3.66M | 0.00 | 0.00 |
Vir Biotechnology IncSOLE | COM | 788.12K | SH | $19.33M 1.27% | 788.12K | 0.00 | 0.00 |
Geron CorpSOLE | COM | 5.43M | SH | $17.43M 1.14% | 5.43M | 0.00 | 0.00 |
Baxter Intl IncSOLE | COM | 362.20K | SH | $16.50M 1.08% | 362.20K | 0.00 | 0.00 |
IDEAYA Biosciences IncSOLE | COM | 664.75K | SH | $15.62M 1.02% | 664.75K | 0.00 | 0.00 |
ImmunoGen IncSOLE | COM | 827.32K | SH | $15.61M 1.02% | 827.32K | 0.00 | 0.00 |
Page 1 of 2